These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2311444)

  • 41. Dose ranging study and constant infusion evaluation of ciprofloxacin.
    Drusano GL; Plaisance KI; Forrest A; Standiford HC
    Antimicrob Agents Chemother; 1986 Sep; 30(3):440-3. PubMed ID: 3777907
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Disposition kinetics of ciprofloxacin in lactating goats.
    el-Banna HA; Abo el-Sooud K
    Dtsch Tierarztl Wochenschr; 1998 Jan; 105(1):35-8. PubMed ID: 9499632
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Competitive inhibition of renal tubular secretion of ciprofloxacin and metabolite by probenecid.
    Landersdorfer CB; Kirkpatrick CM; Kinzig M; Bulitta JB; Holzgrabe U; Jaehde U; Reiter A; Naber KG; Rodamer M; Sörgel F
    Br J Clin Pharmacol; 2010 Feb; 69(2):167-78. PubMed ID: 20233180
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A possible reduction in the renal clearance of ciprofloxacin by fenbufen in rats.
    Naora K; Katagiri Y; Ichikawa N; Hayashibara M; Iwamoto K
    J Pharm Pharmacol; 1990 Oct; 42(10):704-7. PubMed ID: 1982142
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetics and residues of ciprofloxacin and its metabolites in broiler chickens.
    Anadón A; Martínez-Larrañaga MR; Iturbe J; Martínez MA; Díaz MJ; Frejo MT; Martínez M
    Res Vet Sci; 2001 Oct; 71(2):101-9. PubMed ID: 11883887
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics of cefotaxime after a single intravenous dose in patients with impaired renal function.
    Moukhtar I; Nawishy S; Sabbour M
    Chemioterapia; 1987 Feb; 6(1):38-40. PubMed ID: 3829135
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The role of ciprofloxacine metabolites in its biliary and urinary elimination in man].
    Brogard JM; Jehl F; Blickle JF; Arnaud JP; Monteil H
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):719-23. PubMed ID: 3054754
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationships between renal function and disposition of oral ciprofloxacin.
    Forrest A; Weir M; Plaisance KI; Drusano GL; Leslie J; Standiford HC
    Antimicrob Agents Chemother; 1988 Oct; 32(10):1537-40. PubMed ID: 3190182
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics of ciprofloxacin XR (1000 mg) versus levofloxacin (500 mg) in plasma and urine of male and female healthy volunteers receiving a single oral dose.
    Wagenlehner FM; Kinzig-Schippers M; Tischmeyer U; Wagenlehner C; Sörgel F; Dalhoff A; Naber KG
    Int J Antimicrob Agents; 2006 Jan; 27(1):7-14. PubMed ID: 16343856
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Steady-state pharmacokinetics of ciprofloxacin in plasma from patients with nosocomial pneumonia: penetration of the bronchial mucosa.
    Fabre D; Bressolle F; Gomeni R; Arich C; Lemesle F; Beziau H; Galtier M
    Antimicrob Agents Chemother; 1991 Dec; 35(12):2521-5. PubMed ID: 1810184
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tolerance of intravenously administered ciprofloxacin.
    Thorsteinsson SB; Bergan T; Rohwedder R
    Chemotherapy; 1988; 34(3):256-60. PubMed ID: 3416662
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and safety of higher-dose intravenous ciprofloxacin in severe hospital-acquired infections.
    Kljucar S; Heimesaat M; von Pritzbuer E; Timm J; Scholl H; Beermann D
    Am J Med; 1989 Nov; 87(5A):52S-56S. PubMed ID: 2589385
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetics of intravenously administered ciprofloxacin in intensive care patients with acute renal failure.
    Dirksen MS; Vree TB
    Pharm Weekbl Sci; 1986 Feb; 8(1):35-9. PubMed ID: 2938069
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of cardiopulmonary bypass surgery on intravenous ciprofloxacin disposition.
    Pryka RD; Rodvold KA; Ting W; Levitsky S; Frost RW; Lettieri JT
    Antimicrob Agents Chemother; 1993 Oct; 37(10):2106-11. PubMed ID: 8257131
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Disposition kinetics and urinary excretion of ciprofloxacin in goats following single intravenous administration.
    Raina R; Prawez S; Dimitrova DJ; Pankaj NK; Verma PK
    J Vet Sci; 2008 Sep; 9(3):241-5. PubMed ID: 18716443
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ciprofloxacin biliary disposition in cholecystectomised patients with special references to HPLC and bioassay data.
    Jehl F; Adloff M; Monteil H; Brogard JM
    Eur J Drug Metab Pharmacokinet; 1987; 12(2):115-22. PubMed ID: 3691576
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics of ciprofloxacin after oral and parenteral administration.
    Höffken G; Lode H; Prinzing C; Borner K; Koeppe P
    Antimicrob Agents Chemother; 1985 Mar; 27(3):375-9. PubMed ID: 3158275
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prospective use of optimal sampling theory: steady-state ciprofloxacin pharmacokinetics in critically ill trauma patients.
    Yuen GJ; Drusano GL; Forrest A; Plaisance K; Caplan ES
    Clin Pharmacol Ther; 1989 Oct; 46(4):451-7. PubMed ID: 2791447
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Distribution of ciprofloxacin into the central nervous system in rats with acute renal or hepatic failure.
    Naora K; Ichikawa N; Hirano H; Iwamoto K
    J Pharm Pharmacol; 1999 May; 51(5):609-16. PubMed ID: 10411221
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multiple-dose pharmacokinetics of ciprofloxacin administered intravenously to normal volunteers.
    Gonzalez MA; Moranchel AH; Duran S; Pichardo A; Magana JL; Painter B; Forrest A; Drusano GL
    Antimicrob Agents Chemother; 1985 Aug; 28(2):235-9. PubMed ID: 2939794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.